Hemostatic (Antihemorrhagic) Drugs
Hemostatic drugs, also known as antihemorrhagic drugs, are medications used to stop or control bleeding. They promote clot formation or prevent excessive bleeding in medical conditions, surgeries, or injuries.
Classification
- Antifibrinolytics: Tranexamic acid, Aminocaproic acid
- Clotting Factors: Factor VIII concentrate, Factor IX concentrate
- Platelet Aggregation Inhibitors: Aspirin, Clopidogrel
- Desmopressin (DDAVP)
- Vitamin K
Pharmacodynamics (Mechanism of Action)
- Antifibrinolytics:
- Block plasmin activity, preventing fibrin clot breakdown.
- Enhance clot stability, promoting hemostasis.
- Clotting Factor Concentrates:
- Replace deficient clotting factors in conditions like hemophilia.
- Improve blood coagulation and reduce bleeding episodes.
- Platelet Aggregation Inhibitors:
- Prevent platelet aggregation, reducing excessive clot formation.
- Used to prevent thrombotic events (e.g., heart attacks, strokes).
- Desmopressin (DDAVP):
- Stimulates release of von Willebrand factor and Factor VIII.
- Enhances platelet adhesion and coagulation.
- Vitamin K:
- Essential for synthesis of clotting factors II (prothrombin), VII, IX, X.
- Improves blood coagulation in conditions like vitamin K deficiency or warfarin overdose.
Side Effects
- Common:
- Thromboembolic events (increased clotting risk).
- Hypersensitivity reactions (rash, swelling).
- Gastrointestinal disturbances (nausea, vomiting).
- Localized reactions (pain, irritation at injection site).
- Fluid retention (especially with DDAVP).
- Rare but Severe:
- Disseminated Intravascular Coagulation (DIC).
- Severe allergic reactions (anaphylaxis).
- Hepatic dysfunction (especially with Vitamin K overdose).
- Renal impairment (Aminocaproic acid).
- Thrombocytopenia (low platelet count).